{"id":"W1589654967","doi":"10.1056/nejmoa1409547","title":"Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1621,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Ivacaftor; Medicine; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Placebo; Randomization; Internal medicine; Clinical endpoint; Gastroenterology; Randomized controlled trial; Urology; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004572141,0.0002586793,0.0006601539,0.0001658897,0.000147929,0.0002254348,0.0001513088,0.0002507491,0.001538113],"category_scores_gemma":[0.0006849121,0.00008275402,0.0003468462,0.000201941,0.0001626854,0.0001460978,0.0001216563,0.000415899,0.0001914087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002885129,"about_ca_system_score_gemma":0.0002836621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006678251,"about_ca_topic_score_gemma":0.002427362,"domain_scores_codex":[0.9997635,0.0001140423,0.0000181858,0.00002983204,0.00003938347,0.00003500711],"domain_scores_gemma":[0.9997508,0.00006545092,0.00009741914,0.000007865889,0.00001610138,0.00006238049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1527217,0.0041781,0.2376214,0.002129702,0.00207289,0.001115584,0.0002353058,0.001229312,0.02317075,0.0001826783,0.004904366,0.5704382],"study_design_scores_gemma":[0.06190053,0.2257934,0.6789765,0.0007832437,0.003100795,0.004245616,0.000387528,0.003846628,0.00714371,0.0002848053,0.01348815,0.00004914702],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9781124,0.01923786,0.0001860806,0.0004125976,0.00006412916,0.00009084028,0.0001089225,0.00002188952,0.001765172],"genre_scores_gemma":[0.9973456,0.001975854,0.0001838304,0.0001185864,0.00006277989,0.0000284507,0.00008253937,0.000001521555,0.000200878],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001538113,"threshold_uncertainty_score":0.005145431,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01897476457399061,"score_gpt":0.2954351084460771,"score_spread":0.2764603438720865,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}